摘要
目的：评价腹膜透析（ＰＤ）治疗急性肾功能衰竭（ＡＲＦ）的疗效及适应征。方法：６６例急 性肾衰患者分为两组，腹透组２４例，血透组４２例，比较两组患者的临床资料、治疗方法和预后。结 果：腹透组和血透组少尿期持续时间分别为（２３．１±１４．４）天和（１９．８±１０．４）天（Ｐ＞０．０５），病死率 分别为２５％和３１％（Ｐ＞０．０５），其中“高分解代谢”病死率分别为２７．２％和２５％（Ｐ＞０．０５），腹透 组和血透组肾功能完全恢复者分别为 ６３％和 ６４％（Ｐ＞０．０５）。结论：腹膜透析是治疗急性肾功能 衰竭的有效方法之一，且也适用于“高分解代谢”及有并发症的急性肾衰。
Objective: To evaluate effects and indication of peritontal dialysis in the therapy of acute renal failures (ARF). Method: 66 cases of ARF were divided into two groups. Peritontal dialysis 24 cases, hemodialysis 42 cases. Compared the clinical data,therapeutic method and prognosis of these two grous. Result:Duration of oliguria in peritontal dialysis and hemodialysis were (23.1±14.4 ) days and (19. 8±10.4) days respectively (P>0.05). Death rates were 23% and 31 % respectively (P>0.05 ). Among them'high resolving metabolism' in death rate were 27.2 % and 25% respectively (P>0.05). Conclusion: Peritontal dialysis is one of the effective method in the therapy of ARF. It also adapts to 'high resolving emtoblism' and other complications.
出处
《透析与人工器官》
2001年第2期10-12,共3页
Chinese Journal of Dialysis and Artificial Organs
